FORT LAUDERDALE, FL, Jan. 24, 2018 --
SanSal Wellness Holdings, Inc. (“SanSal Wellness” or the “Company”) (OTC PINK: SSWH), a vertically-integrated agribusiness focused on producing full spectrum natural phytocannabinoid-rich industrial hemp extracts, today announced that the Company has filed an application with OTC Markets Group, Inc. for SSWH shares to be uplisted for trading on the OTCQB tier of the over-the-counter market maintained by OTC Markets Group.
“We are very confident that SanSal Wellness meets all of the auditing, financial, and management reporting requirements to have its shares listed for trading on the more senior OTCQB market tier,” stated Alexander M. Salgado, CEO and co-founder of SanSal Wellness. “By uplisting to the more transparent and reputable OTCQB, our current stakeholders and potential investors will have even greater confidence in our business strategy, management team, operations, products, and long-term value-building goals. We look forward to utilizing the increased investor visibility once the market uplist is complete, as well as additional liquidity for our shares.”
The application to trade on the OTCQB® Venture Market is subject to review and approval by OTC Markets Group. The Company anticipates the application will be reviewed and approved within the next 10 to 14 days.
About SanSal Wellness Holdings, Inc.
SanSal Wellness Holdings, Inc. (OTC Pink: SSWH) is focused on producing superior quality, whole-plant, broad spectrum phytocannabinoid-rich hemp oils and extracts. SanSal Wellness currently operates a 140-acre farm and production facilities in Pueblo, Colorado, and is registered with the Colorado Department of Agriculture to grow industrial hemp. The Company files periodic reports with the Securities and Exchange Commission, which can be viewed at www.sec.gov.
For additional information, visit www.sansalwellness.com
Cautionary Language Concerning Forward-Looking Statements
This SanSal Wellness Holdings, Inc. press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact, including those with respect to the Company’s mission statement and growth strategy, are “forward-looking statements.” Although the Company's management believes that such forward-looking statements are reasonable, it cannot guarantee that such expectations are, or will be, correct. These forward-looking statements involve many risks and uncertainties, which could cause the Company’s future results to differ materially from those anticipated. Potential risks and uncertainties include, among others, general economic conditions and conditions affecting the industries in which the Company operates; the uncertainty of regulatory requirements and approvals; and the ability to obtain necessary financing on acceptable terms or at all. Additional information regarding the factors that may cause actual results to differ materially from these forward-looking statements is available in the Company’s filings with the Securities and Exchange Commission. The Company assumes no obligation to update any of the information contained or referenced in this press release.
SanSal Wellness Holdings, Inc. - IR/Media Contact Toll-Free: (888) 549-7888 E-mail: [email protected]


Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Instagram Outage Disrupts Thousands of U.S. Users
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO 



